Skip to search formSkip to main contentSkip to account menu

0.5 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega]

Known as: 0.5 ML Invega Sustenna 156 MG/ML Prefilled Syringe, Invega Sustenna 78 MG per 0.5 ML Prefilled Syringe, paliperidone palmitate 78 mg in 0.5 mL INTRAMUSCULAR INJECTION [INVEGA SUSTENNA] 
National Institutes of Health

Related topics

Related topics

11 relations
InvegaPolysorbate 20Prefilled SyringeSODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Need for Bioequivalence Standards that Reflect the Clinical Importance of the Complex Pharmacokinetics of Paliperidone Palmitate Long-Acting Injectable Suspension.
Paliperidone palmitate is a second generation antipsychotic, approved for the treatment of schizophrenia in the form of the long… 
2012
2012
Anaphylactoid reaction to paliperidone palmitate extended-release injectable suspension in a patient tolerant of oral risperidone.
PURPOSE A probable anaphylactoid reaction to the injectable formulation of the atypical antipsychotic paliperidone in a patient… 
2011
2011
Gates eyes biotechs as for-profit investments
2011
2011
Alkermes, Elan in $960 million merger
In May, the drugdelivery specialist Alkermes announced it would merge with Elan Drug Technologies (EDT), the chemical formulation… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)